State of Wisconsin Investment Board
APGE icon

State of Wisconsin Investment Board’s Apogee Therapeutics APGE Stock Holding History

State of Wisconsin Investment Board’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72M Buy
20,456
+143
+0.7% +$10.4K ﹤0.01% 1459
2025
Q4 		$1.53M Buy
20,313
+12,218
+151% +$770K ﹤0.01% 1509
2025
Q3 		$322K Sell
8,095
-4,210
-34% -$161K ﹤0.01% 2078
2025
Q2 		$534K Buy
12,305
+3,814
+45% +$145K ﹤0.01% 1825
2025
Q1 		$317K Sell
8,491
-4,902
-37% -$190K ﹤0.01% 1946
2024
Q4 		$607K Buy
13,393
+5,201
+63% +$265K ﹤0.01% 1721
2024
Q3 		$481K Sell
8,192
-1,233
-13% -$59.1K ﹤0.01% 1887
2024
Q2 		$371K Sell
9,425
-661
-7% -$32.1K ﹤0.01% 1962
2024
Q1 		$670K Sell
10,086
-3,700
-27% -$162K ﹤0.01% 1594
2023
Q4 		$385K Buy
+13,786
New +$276K ﹤0.01% 1902

Other funds holding APGE

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

State of Wisconsin Investment Board's APGE Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Apogee Therapeutics (APGE) stake by 0.7% in Q1 2026, buying an estimated $10.4K and bringing the position to 20,456 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1459.

State of Wisconsin Investment Board first reported a position in APGE in Q4 2023 and has held it in 10 quarters since. 224 funds tracked by Wall St. Rank hold APGE as of Q1 2026.

  • State of Wisconsin Investment Board held 20,456 shares of Apogee Therapeutics worth $1.72M as of Q1 2026.
  • State of Wisconsin Investment Board bought 143 Apogee Therapeutics shares in Q1 2026, an estimated $10.4K.
  • Apogee Therapeutics made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1459 holding.
  • State of Wisconsin Investment Board first reported a position in Apogee Therapeutics in Q4 2023 and has held it in 10 quarters since.
  • 224 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.